Seth Lerner, MD

Baylor College of Medicine – Houston, TX

Seth P. Lerner, M.D., is Professor of Urology and holds the Beth and Dave Swalm Chair in Urologic Oncology and is Vice-chair for faculty affairs in the Scott Department of Urology, Baylor College of Medicine. He earned his M.D. degree from Baylor College of Medicine and completed two years of General Surgery training at Virginia Mason Clinic in Seattle before returning to Baylor to complete his residency training in Urology. After a one-year AFUD/National Kidney Foundation fellowship and a one-year American Cancer Society fellowship in urologic oncology at the University of Southern California, he returned to Houston in 1992 to join the faculty of the Scott Department of Urology.

Scholar and teacher, author of more than 210 peer-reviewed articles, and co-editor of a widely used comprehensive Textbook of Bladder Cancer, Dr. Lerner is an active member of the prestigious American Association of Genitourinary surgeons and is listed routinely among “America’s Top Doctors” and “Best Doctors in America.” He is co-chair of the National Cancer Institute’s Genitourinary Cancer Steering Committee and bladder cancer disease working group for The Cancer Genome Atlas Project. He chairs the Local Bladder Committee of SWOG and serves on the Board of Directors for the Bladder Cancer Advocacy Network. He is active in international CME programs for the AUA, SUO, and ASCO and has served as Visiting Professor in places as varied as China, Australia, Germany, Korea, and Turkey. He is the founding co-editor-in-chief of the Bladder Cancer Journal and directs the Multi-disciplinary bladder cancer research program at Baylor.

His research interests include use of selective estrogen receptor modulators for treatment of bladder cancer, gene therapy, targeted molecular therapeutics, and outcomes of radical cystectomy and pelvic lymphadenectomy. He has 28 years of experience as a clinical investigator for both NCI and industry funded clinical trials and currently serves as principle investigator for multiple clinical trials related to bladder cancer diagnosis and treatment.